IAMERS SUPPORTS ITS MEMBERS IN MANY WAYS.
Networking, Education, Patient Safety and Advocacy. With declining provider revenues, stronger business practices and an industry in transition, you need to know information critical to your business. IAMERS is following what matters most to your business.
Our efforts are gaining recognition and momentum as the marketplace is recognizing the importance and cost effectiveness of the Independent Provider of services and devices. For many if these less expensive, but clinically relevant, options were not available then their patients would miss receiving the health care they need and deserve.
Take the time to learn about our efforts in the regulatory and legislative arenas.
FDA Holds Off on UDI Label Enforcement for Devices Made Before September 2021
The FDA announced it does not intend to enforce the requirement to use its unique device identifier system for labels on medical devices manufactured and labeled before Sept. 24, 2021. [...]
An in-depth look at the FDA’s refurb docket
Why is this happening now? According to the docket itself, the FDA’s renewed interest in refurbishment came as a response to safety concerns brought to its attention. It’s also a [...]
FDA announces public workshop to discuss third-party refurb docket
Now that the commenting period has ended, the FDA plans to host a two-day public workshop for stakeholders to discuss the questions raised in its third-party service and refurbished medical [...]